[细胞学诊断的转移性清晰细胞细胞癌的病理特征]
1Department of Pathology, the First Affiliated Hospital of Air Force Medical University, Xi'an 710032, China.
Zhonghua bing li xue za zhi = Chinese journal of pathology
|November 3, 2025
概括
转移性清晰细胞细胞癌 (CCRCC) 呈现出多样化的细胞病理特征,通常模仿各种部位的原发性瘤. 准确的诊断依赖于形态学,免疫细胞化学和临床史.
科学领域:
- 在瘤学瘤学.
- 病理学 病理学 病理学
- 细胞病理学 细胞病理学
背景情况:
- 转移性清晰细胞细胞癌 (CCRCC) 由于表现多样,造成了诊断挑战.
- 准确的细胞病理学表征对于有效的患者管理至关重要.
研究的目的:
- 调查转移性CCRCC的临床,细胞病理学特征和差异诊断.
- 突出诊断挑战,并强调辅助技术的作用.
主要方法:
- 对9例转移性CCRCC病例的回顾性分析.
- 使用了HE染色,梅-格鲁内瓦尔德-吉姆萨染色,基于液体的细胞学,细胞块和免疫细胞化学.
- 与临床数据和文献综述相关的细胞病理学发现.
主要成果:
- 转移发生在淋巴结,骨,甲状腺,上腺,肺和胰腺.
- 瘤细胞表现出多样化的模式,细胞质丰富 (清晰或好色素) 和轻微的核类型异常.
- 免疫细胞化学证实了PAX8,CAIX,CD10和CKpan的阳性.
结论:
- 转移性CCRCC细胞学通常具有均的细胞,丰富的透明细胞质和轻微的异型.
- 不同诊断需要仔细考虑转移部位的原发性瘤.
- 免疫细胞化学和分子检测对于准确诊断和避免误诊至关重要.
相关概念视频
Metastasis
6.4K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.4K
Adaptive Mechanisms in Cancer Cells
6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Tumor Progression
7.2K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Cancer Stem Cells and Tumor Maintenance
5.9K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.9K


